Unanticipated Structural and Functional Properties of δ-Subunit-containing GABAA Receptors*
- 1 To whom correspondence should be addressed: Institute of Biochemistry and Molecular Medicine, University of Bern, Bühlstrasse 28, CH-3012, Switzerland. Fax: 41-31-631-3737; E-mail: erwin.sigel{at}mci.unibe.ch.
Abstract
GABAA receptors mediate inhibitory neurotransmission in the mammalian brain via synaptic and extrasynaptic receptors. The delta (δ)-subunit-containing receptors are expressed exclusively extra-synaptically and mediate tonic inhibition. In the present study, we were interested in determining the architecture of receptors containing the δ-subunit. To investigate this, we predefined the subunit arrangement by concatenation. We prepared five dual and three triple concatenated subunit constructs. These concatenated dual and triple constructs were used to predefine nine different GABAA receptor pentamers. These pentamers composed of α1-, β3-, and δ-subunits were expressed in Xenopus oocytes and maximal currents elicited in response to 1 mm GABA were determined in the presence and absence of THDOC (3α, 21-dihydroxy-5α-pregnane-20-one). β3-α1-δ/α1-β3 and β3-α1-δ/β3-α1 resulted in the expression of large currents in response to GABA. Interestingly, the presence of the neurosteroid THDOC uncovered α1-β3-α1/β3-δ receptors, additionally. The functional receptors were characterized in detail using the agonist GABA, THDOC, Zn2+, and ethanol and their properties were compared with those of non-concatenated α1β3 and α1β3δ receptors. Each concatenated receptor isoform displayed a specific set of properties, but none of them responded to 30 mm ethanol. We conclude from the investigated receptors that δ can assume multiple positions in the receptor pentamer. The GABA dose-response properties of α1-β3-α1/β3-δ and β3-α1-δ/α1-β3 match most closely the properties of non-concatenated α1β3δ receptors. Furthermore, we show that the δ-subunit can contribute to the formation of an agonist site in α1-β3-α1/β3-δ receptors.
Footnotes
-
↵2 The abbreviations used are: GABAA receptor, γ-aminobutyric acid type A receptor; THDOC, 3α,21-dihydroxy-5α-pregnane-20-one.
-
↵3 E. Sigel, unpublished observations.
-
↵* This work was supported by the Swiss National Science Foundation Grants 3100A0-105272/1 and 3100A0-105272/2. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Received August 21, 2008.
- Revision received January 5, 2009.
- The American Society for Biochemistry and Molecular Biology, Inc.











